NCT04690374 Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
| NCT ID | NCT04690374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Desmoplastic Small Round Cell Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2020-12-22 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2020-12-22 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.
Eligibility Criteria
Inclusion Criteria: * Participants must have a diagnosis of desmoplastic small round cell tumor * Participants may be of any age as long as the appropriate consent and assent may be obtained * Willing to provide historical and longitudinal clinical data Exclusion Criteria: * Participant unwilling to provide consent or share historical and longitudinal clinical data
Contact & Investigator
Emily Slotkin, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT04690374 clinical trial?
This trial is open to participants of all sexes, studying Desmoplastic Small Round Cell Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04690374 currently recruiting?
Yes, NCT04690374 is actively recruiting participants. Contact the research team at slotkine@mskcc.org for enrollment information.
Where is the NCT04690374 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04690374 clinical trial?
NCT04690374 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Emily Slotkin, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 250 participants.